$NBY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovaBay Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NovaBay Pharmaceuticals, Inc.. Get notifications about new insider transactions in NovaBay Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 1,216 | 0 | 14,466 | 13.3 K to 14.5 K (+9.18 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 263 | 0 | 13,250 | 13.5 K to 13.3 K (-1.95 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,216 | 0 | 31,081 | 29.9 K to 31.1 K (+4.07 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 263 | 0 | 29,865 | 29.6 K to 29.9 K (+0.89 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 1,216 | 0 | 137,513 | 136.3 K to 137.5 K (+0.89 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 526 | 0 | 136,297 | 135.8 K to 136.3 K (+0.39 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 1,216 | 0 | 5,959 | 4.7 K to 6 K (+25.64 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 1,216 | 0 | 201,462 | 200.2 K to 201.5 K (+0.61 %) |
Apr 18 2008 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 1,216 | 0 | 143,178 | 142 K to 143.2 K (+0.86 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP, Research & Dev' ... | Buy | P | 2.72 | 500 | 1,360 | 500 | 0 to 500 |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | Chief Financial Off ... | Buy | P | 2.70 | 2,000 | 5,400 | 2,000 | 0 to 2 K |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Buy | P | 2.75 | 3,000 | 8,250 | 10,180 | 7.2 K to 10.2 K (+41.78 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | P | 2.97 | 500 | 1,485 | 500 | 0 to 500 |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.75 | 2,000 | 5,500 | 3,600 | 1.6 K to 3.6 K (+125.00 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.50 | 600 | 1,500 | 1,600 | 1,000 to 1.6 K (+60.00 %) |
Mar 18 2008 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 2.77 | 1,000 | 2,770 | 1,000 | 0 to 1,000 |
Mar 17 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | P | 2.41 | 100 | 241 | 200,246 | 200.1 K to 200.2 K (+0.05 %) |
Mar 17 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | P | 2.45 | 1,900 | 4,655 | 200,146 | 198.2 K to 200.1 K (+0.96 %) |
Mar 17 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | P | 2.35 | 500 | 1,175 | 198,246 | 197.7 K to 198.2 K (+0.25 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 1,015 | 0 | 4,743 | 3.7 K to 4.7 K (+27.23 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,015 | 0 | 29,602 | 28.6 K to 29.6 K (+3.55 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 1,015 | 0 | 197,746 | 196.7 K to 197.7 K (+0.52 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 1,015 | 0 | 135,771 | 134.8 K to 135.8 K (+0.75 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 1,015 | 0 | 141,962 | 140.9 K to 142 K (+0.72 %) |
Mar 07 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 1,015 | 0 | 12,987 | 12 K to 13 K (+8.48 %) |
Mar 04 2008 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 1,387 | 0 | 3,728 | 2.3 K to 3.7 K (+59.25 %) |
Mar 04 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,173 | 0 | 28,587 | 27.4 K to 28.6 K (+4.28 %) |
Mar 04 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 960 | 0 | 196,731 | 195.8 K to 196.7 K (+0.49 %) |
Mar 04 2008 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 1,440 | 0 | 134,756 | 133.3 K to 134.8 K (+1.08 %) |
Feb 13 2008 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 411 | 0 | 133,316 | 132.9 K to 133.3 K (+0.31 %) |
Mar 04 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 960 | 0 | 11,972 | 11 K to 12 K (+8.72 %) |
Feb 13 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 205 | 0 | 27,414 | 27.2 K to 27.4 K (+0.75 %) |
Feb 13 2008 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 205 | 0 | 140,947 | 140.7 K to 140.9 K (+0.15 %) |
Jan 16 2008 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | Chief Financial Off ... | Option Exercise | A | 3.80 | 200,000 | 760,000 | 200,000 | |
Feb 13 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 205 | 0 | 11,012 | 10.8 K to 11 K (+1.90 %) |
Jan 15 2008 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 1,007 | 0 | 2,341 | 1.3 K to 2.3 K (+75.49 %) |
Jan 15 2008 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 697 | 0 | 195,771 | 195.1 K to 195.8 K (+0.36 %) |
Jan 15 2008 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 1,162 | 0 | 27,209 | 26 K to 27.2 K (+4.46 %) |
Jan 15 2008 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 852 | 0 | 140,742 | 139.9 K to 140.7 K (+0.61 %) |
Jan 15 2008 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 1,007 | 0 | 10,807 | 9.8 K to 10.8 K (+10.28 %) |
Dec 18 2007 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 3.56 | 125,000 | 445,000 | 125,000 | |
Dec 18 2007 | NBY | NovaBay Pharmaceut ... | O'Reilly John James | Chief Financial Off ... | Option Exercise | A | 3.56 | 50,000 | 178,000 | 50,000 | |
Dec 18 2007 | NBY | NovaBay Pharmaceut ... | Scott Colin | VP, Clinical Resear ... | Option Exercise | A | 3.56 | 37,500 | 133,500 | 37,500 | |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 698 | 0 | 26,047 | 25.3 K to 26 K (+2.75 %) |
Dec 18 2007 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP, Research & Dev' ... | Option Exercise | A | 3.56 | 37,500 | 133,500 | 37,500 | |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 698 | 0 | 139,890 | 139.2 K to 139.9 K (+0.50 %) |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 821 | 0 | 132,905 | 132.1 K to 132.9 K (+0.62 %) |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 698 | 0 | 9,800 | 9.1 K to 9.8 K (+7.67 %) |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 575 | 0 | 1,334 | 759 to 1.3 K (+75.76 %) |
Dec 17 2007 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Grant | A | 0.00 | 575 | 0 | 195,074 | 194.5 K to 195.1 K (+0.30 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 119 | 0 | 139,192 | 139.1 K to 139.2 K (+0.09 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 117 | 0 | 139,073 | 139 K to 139.1 K (+0.08 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 239 | 0 | 132,084 | 131.8 K to 132.1 K (+0.18 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 235 | 0 | 131,845 | 131.6 K to 131.8 K (+0.18 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 119 | 0 | 9,102 | 9 K to 9.1 K (+1.32 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 117 | 0 | 8,983 | 8.9 K to 9 K (+1.32 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 119 | 0 | 25,349 | 25.2 K to 25.3 K (+0.47 %) |
Dec 12 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 117 | 0 | 25,230 | 25.1 K to 25.2 K (+0.47 %) |
Nov 15 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Grant | A | 0.00 | 533 | 0 | 8,866 | 8.3 K to 8.9 K (+6.40 %) |
Nov 15 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 533 | 0 | 131,610 | 131.1 K to 131.6 K (+0.41 %) |
Nov 15 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Grant | A | 0.00 | 533 | 0 | 138,956 | 138.4 K to 139 K (+0.39 %) |
Nov 15 2007 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 533 | 0 | 759 | 226 to 759 (+235.84 %) |
Nov 07 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Grant | A | 0.00 | 113 | 0 | 131,077 | 131 K to 131.1 K (+0.09 %) |
Nov 07 2007 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Grant | A | 0.00 | 226 | 0 | 226 | 0 to 226 |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | C | 0.00 | 30,000 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | C | 0.00 | 71,429 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Buy | C | 0.00 | 15,000 | 0 | 130,964 | 116 K to 131 K (+12.94 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Buy | C | 0.00 | 35,714 | 0 | 115,964 | 80.3 K to 116 K (+44.50 %) |
Nov 07 2007 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Grant | A | 0.00 | 113 | 0 | 25,113 | 25 K to 25.1 K (+0.45 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | C | 0.00 | 142,857 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | P | 4.00 | 67,500 | 270,000 | 194,499 | 127 K to 194.5 K (+53.15 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Buy | C | 0.00 | 71,428 | 0 | 126,999 | 55.6 K to 127 K (+128.53 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | C | 0.00 | 16,666 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Buy | C | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | C | 0.00 | 17,647 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | C | 0.00 | 32,000 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | C | 0.00 | 10,638 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | C | 0.00 | 57,143 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Sell | C | 0.00 | 8,823 | 0 | 138,423 | 147.2 K to 138.4 K (-5.99 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Buy | C | 0.00 | 16,000 | 0 | 129,600 | 113.6 K to 129.6 K (+14.08 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Buy | C | 0.00 | 5,319 | 0 | 7,180 | 1.9 K to 7.2 K (+285.81 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Buy | C | 0.00 | 28,572 | 0 | 113,600 | 85 K to 113.6 K (+33.60 %) |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP, Research & Dev' ... | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
Oct 31 2007 | NBY | NovaBay Pharmaceut ... | Khosrovi Behzad | VP, Research & Dev' ... | Buy | C | 0.00 | 100,000 | 0 | 135,000 | 35 K to 135 K (+285.71 %) |